273 related articles for article (PubMed ID: 17262707)
1. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
Schul W; Liu W; Xu HY; Flamand M; Vasudevan SG
J Infect Dis; 2007 Mar; 195(5):665-74. PubMed ID: 17262707
[TBL] [Abstract][Full Text] [Related]
2. Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy.
Watanabe S; Chan KW; Dow G; Ooi EE; Low JG; Vasudevan SG
Antiviral Res; 2016 Mar; 127():10-9. PubMed ID: 26794905
[TBL] [Abstract][Full Text] [Related]
3. The effect of freeze-dried Carica papaya leaf juice treatment on NS1 and viremia levels in dengue fever mice model.
Mohd Abd Razak MR; Mohmad Misnan N; Md Jelas NH; Norahmad NA; Muhammad A; Ho TCD; Jusoh B; Sastu UR; Zainol M; Wasiman MI; Muhammad H; Thayan R; Syed Mohamed AF
BMC Complement Altern Med; 2018 Dec; 18(1):320. PubMed ID: 30518360
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys.
Ajariyakhajorn C; Mammen MP; Endy TP; Gettayacamin M; Nisalak A; Nimmannitya S; Libraty DH
Antimicrob Agents Chemother; 2005 Nov; 49(11):4508-14. PubMed ID: 16251289
[TBL] [Abstract][Full Text] [Related]
5. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.
Rathore AP; Paradkar PN; Watanabe S; Tan KH; Sung C; Connolly JE; Low J; Ooi EE; Vasudevan SG
Antiviral Res; 2011 Dec; 92(3):453-60. PubMed ID: 22020302
[TBL] [Abstract][Full Text] [Related]
6. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
7. Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.
Sung C; Wei Y; Watanabe S; Lee HS; Khoo YM; Fan L; Rathore AP; Chan KW; Choy MM; Kamaraj US; Sessions OM; Aw P; de Sessions PF; Lee B; Connolly JE; Hibberd ML; Vijaykrishna D; Wijaya L; Ooi EE; Low JG; Vasudevan SG
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004851. PubMed ID: 27509020
[TBL] [Abstract][Full Text] [Related]
8. Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial.
Watanabe S; Rathore AP; Sung C; Lu F; Khoo YM; Connolly J; Low J; Ooi EE; Lee HS; Vasudevan SG
Antiviral Res; 2012 Oct; 96(1):32-5. PubMed ID: 22867971
[TBL] [Abstract][Full Text] [Related]
9. Testing antiviral compounds in a dengue mouse model.
Schul W; Yip A; Shi PY
Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
[TBL] [Abstract][Full Text] [Related]
10. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.
Whitby K; Pierson TC; Geiss B; Lane K; Engle M; Zhou Y; Doms RW; Diamond MS
J Virol; 2005 Jul; 79(14):8698-706. PubMed ID: 15994763
[TBL] [Abstract][Full Text] [Related]
11. An iminosugar with potent inhibition of dengue virus infection in vivo.
Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dengue antiviral candidates in vivo in mouse model.
Watanabe S; Vasudevan SG
Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
[TBL] [Abstract][Full Text] [Related]
13. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
14. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.
Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA
Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.
Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC
Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050
[TBL] [Abstract][Full Text] [Related]
17. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
Whitby K; Taylor D; Patel D; Ahmed P; Tyms AS
Antivir Chem Chemother; 2004 May; 15(3):141-51. PubMed ID: 15266896
[TBL] [Abstract][Full Text] [Related]
18. Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
Chang J; Schul W; Butters TD; Yip A; Liu B; Goh A; Lakshminarayana SB; Alonzi D; Reinkensmeier G; Pan X; Qu X; Weidner JM; Wang L; Yu W; Borune N; Kinch MA; Rayahin JE; Moriarty R; Xu X; Shi PY; Guo JT; Block TM
Antiviral Res; 2011 Jan; 89(1):26-34. PubMed ID: 21073903
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
[TBL] [Abstract][Full Text] [Related]
20. Effect of freeze-dried Carica papaya leaf juice on inflammatory cytokines production during dengue virus infection in AG129 mice.
Norahmad NA; Mohd Abd Razak MR; Mohmad Misnan N; Md Jelas NH; Sastu UR; Muhammad A; Ho TCD; Jusoh B; Zolkifli NA; Thayan R; Mat Ripen A; Zainol M; Syed Mohamed AF
BMC Complement Altern Med; 2019 Feb; 19(1):44. PubMed ID: 30744623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
